DES MOINES, Iowa (AP) — A renewed and expanded effort from chemical giant Bayer to shield itself from lawsuits that claim its ...

The study is backed by Bayer (OTC:BAYRY) (ETR: BAYN) and the Ramsay Hospital Research Foundation and will be led by Professor Lisa Horvath from Chris O'Brien Lifehouse and the Australian and New ...

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic ...

Bayer is to buy UK-based KaNDy Therapeutics in a deal worth more than $800 million, adding the biotech’s menopause drug to its women’s health pipeline. Bayer will pay $425 million up front and ...

Though the health agency oversees the Food and Drug Administration, it does not control the EPA and its labeling requirements. The legislation supported by Bayer would provide a defense against ...

Bayer acquires rights to Cytokinetics' heart drug in Japan Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug development ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...